1. Home
  2. DK vs RCUS Comparison

DK vs RCUS Comparison

Compare DK & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DK
  • RCUS
  • Stock Information
  • Founded
  • DK 2001
  • RCUS 2015
  • Country
  • DK United States
  • RCUS United States
  • Employees
  • DK N/A
  • RCUS N/A
  • Industry
  • DK Integrated oil Companies
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • DK Energy
  • RCUS Health Care
  • Exchange
  • DK Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • DK 1.0B
  • RCUS 1.2B
  • IPO Year
  • DK 2006
  • RCUS 2018
  • Fundamental
  • Price
  • DK $16.66
  • RCUS $11.07
  • Analyst Decision
  • DK Sell
  • RCUS Buy
  • Analyst Count
  • DK 10
  • RCUS 11
  • Target Price
  • DK $21.22
  • RCUS $31.11
  • AVG Volume (30 Days)
  • DK 1.1M
  • RCUS 1.1M
  • Earning Date
  • DK 02-25-2025
  • RCUS 02-25-2025
  • Dividend Yield
  • DK 6.08%
  • RCUS N/A
  • EPS Growth
  • DK N/A
  • RCUS N/A
  • EPS
  • DK N/A
  • RCUS N/A
  • Revenue
  • DK $13,870,800,000.00
  • RCUS $263,000,000.00
  • Revenue This Year
  • DK N/A
  • RCUS $127.65
  • Revenue Next Year
  • DK N/A
  • RCUS N/A
  • P/E Ratio
  • DK N/A
  • RCUS N/A
  • Revenue Growth
  • DK N/A
  • RCUS 119.17
  • 52 Week Low
  • DK $15.36
  • RCUS $10.63
  • 52 Week High
  • DK $33.60
  • RCUS $20.31
  • Technical
  • Relative Strength Index (RSI)
  • DK 37.60
  • RCUS 34.34
  • Support Level
  • DK $16.80
  • RCUS $10.63
  • Resistance Level
  • DK $18.79
  • RCUS $13.49
  • Average True Range (ATR)
  • DK 0.91
  • RCUS 0.77
  • MACD
  • DK -0.21
  • RCUS -0.13
  • Stochastic Oscillator
  • DK 0.00
  • RCUS 13.88

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. Delek's logistics segment sells portions of the petroleum products its refineries produce. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: